Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01321086 · ClinicalTrials.gov registry record · NA

Motivational Interviewing (MI) for African Americans With Peripheral Arterial Disease (PAD)

A NA study of Peripheral Arterial Disease, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
174
Enrollment target
2
Study locations

NCT01321086: Completed NA study of Peripheral Arterial Disease, sponsored by University of Kansas Medical Center.

NCT01321086 is a NA study of Peripheral Arterial Disease that has completed, run by University of Kansas Medical Center. The registered enrollment target is 174 participants, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01321086, a NA study of Peripheral Arterial Disease, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
174 participants
Enrollment target
2
Study locations

Study Summary

The investigators are conducting a clinical research trial to determine the role of motivational interviewing (MI) on promoting home-based walking therapy to improve walking ability in African Americans with peripheral arterial disease (PAD). African Americans are more than two times as likely as non-Hispanic whites to suffer from PAD. For patients with PAD, there is a significant risk for poor walking ability and limb loss. One major treatment for PAD is walking therapy but the traditional methods for the delivery of this treatment have required frequent visits to a university or hospital-based site. The investigators will address the role of self-managed walking program, to be conducted at or near the home, to improve limb function. In order to motivate the participants to walk, the investigators included two different intervention strategies: MI and patient-centered counseling for exercise (PACE). The investigators hypothesize that participants randomized to the MI arm will have a greater increase in their walking distance, compared to those receiving Patient-Centered Assessment and Counseling for Exercise (PACE) and the control group.

Primary Outcome

Distance walked in 6 minutes

Interventions

  • BEHAVIORAL Motivational Interviewing
  • BEHAVIORAL PACE

Study Locations (2)

Kansas

  • Clinical and Translational Science Unit - Fairway
  • KU School of Medicine-Wichita - Wichita

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2011-06
Est. Completion 2016-11
Phase NA
University of Kansas Medical Center

408 total trials

What the finished NCT01321086 record still lists

NCT01321086 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing is the first listed.

NCT01321086 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT01321086 about?

NCT01321086 is a clinical study titled "Motivational Interviewing (MI) for African Americans With Peripheral Arterial Disease (PAD)". The investigators are conducting a clinical research trial to determine the role of motivational interviewing (MI) on promoting home-based walking therapy to improve walking ability in African Americans with peripheral arterial disease (PAD). African Americans are more than two times as likely as no...

What is the current status of trial NCT01321086?

This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2011-06. Estimated completion is 2016-11.

What conditions does trial NCT01321086 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT01321086?

The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), PACE (BEHAVIORAL).

Who is sponsoring clinical trial NCT01321086?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01321086 being conducted?

This trial has 2 study locations across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01321086's enrollment target sits among peer trials

174 28th of 79 higher than 52 of 79 other Peripheral Arterial Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01000259 · 174 participants

    Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

  • NCT04729114 · 174 participants · Phase 1

    A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • NCT04884035 · 174 participants · Phase 1

    Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

  • NCT05075980 · 174 participants · Phase 2

    Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01321086, the US trial registry maintained by the National Library of Medicine. NCT01321086 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.